Skip to main content
Top
Published in: Annals of Hematology 3/2021

Open Access 01-03-2021 | Multiple Myeloma | Letter to the Editor

COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan

Authors: Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, Hermann Einsele, Xiaohua Hou, Leo Rasche

Published in: Annals of Hematology | Issue 3/2021

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
2.
go back to reference Robak P, Drozdz I, Szemraj J, Robak T (2018) Drug resistance in multiple myeloma. Cancer Treat Rev 70:199–208CrossRef Robak P, Drozdz I, Szemraj J, Robak T (2018) Drug resistance in multiple myeloma. Cancer Treat Rev 70:199–208CrossRef
3.
go back to reference Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49(8):1211–1225CrossRef Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49(8):1211–1225CrossRef
4.
go back to reference Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364(11):1046–1060CrossRef Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364(11):1046–1060CrossRef
5.
go back to reference He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP (2020) COVID-19 in persons with haematological cancers. Leukemia. 34(6):1637–1645CrossRef He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP (2020) COVID-19 in persons with haematological cancers. Leukemia. 34(6):1637–1645CrossRef
6.
go back to reference Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M et al (2020) Clinical outcome of coronavirus disease 2019 in haemato-oncology patients. Br J Haematol Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M et al (2020) Clinical outcome of coronavirus disease 2019 in haemato-oncology patients. Br J Haematol
7.
go back to reference Cook G, John Ashcroft A, Pratt G, Popat R, Ramasamy K, Kaiser M et al (2020) Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol Cook G, John Ashcroft A, Pratt G, Popat R, Ramasamy K, Kaiser M et al (2020) Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol
8.
go back to reference Dhakal B, D'Souza A, Chhabra S, Hari P (2020) Multiple myeloma and COVID-19. Leukemia. 34:1961–1963CrossRef Dhakal B, D'Souza A, Chhabra S, Hari P (2020) Multiple myeloma and COVID-19. Leukemia. 34:1961–1963CrossRef
9.
go back to reference Dufour I, Raedemaeker J, Andreozzi F, Verstraete G, Bailly S, Delforge M, Storms P, Jacquy C, van de Velde A, Mineur P, Lejeune M, Bauwens D, van Obbergh F, Kentos A, Nguyen J, Fostier K, de Weweire A, Meuleman N, Vekemans MC (2020) COVID-19, impact on myeloma patients. Ann Hematol 99:1947–1949CrossRef Dufour I, Raedemaeker J, Andreozzi F, Verstraete G, Bailly S, Delforge M, Storms P, Jacquy C, van de Velde A, Mineur P, Lejeune M, Bauwens D, van Obbergh F, Kentos A, Nguyen J, Fostier K, de Weweire A, Meuleman N, Vekemans MC (2020) COVID-19, impact on myeloma patients. Ann Hematol 99:1947–1949CrossRef
10.
go back to reference Wang Y, Li J, Liu L, Li J, Liu X, He J, Wang C, Ye D, Wang X, Zhou F (2020) Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Ann Hematol 99:1933–1938CrossRef Wang Y, Li J, Liu L, Li J, Liu X, He J, Wang C, Ye D, Wang X, Zhou F (2020) Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Ann Hematol 99:1933–1938CrossRef
11.
go back to reference Terpos E, Engelhardt M, Cook G, Gay F, Mateos MV, Ntanasis-Stathopoulos I et al (2020) Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. Terpos E, Engelhardt M, Cook G, Gay F, Mateos MV, Ntanasis-Stathopoulos I et al (2020) Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia.
Metadata
Title
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan
Authors
Xiang Zhou
Tao Bai
Katharina Meckel
Jun Song
Yu Jin
K. Martin Kortüm
Hermann Einsele
Xiaohua Hou
Leo Rasche
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2021
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04184-2

Other articles of this Issue 3/2021

Annals of Hematology 3/2021 Go to the issue